While the FIGO system is widely used, it has some limitations. For instance, it primarily focuses on the anatomical spread of the tumor and does not include molecular markers or genetic information, which can be crucial for personalized treatment strategies. Additionally, staging might vary slightly between different types of gynecologic cancers, necessitating specialized knowledge for accurate interpretation.
